The startup develops cloud-based medical assessment devices that utilize integrated artificial intelligence to enhance the management of patients with aortic aneurysms. By providing precise, personalized treatment recommendations, the platform enables healthcare providers to deliver timely and effective care tailored to individual patient needs.
Funding
$6.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing abdominal aortic aneurysms (AAA) rely primarily on dimensional measurements, which provide an incomplete picture of aneurysm stability and optimal intervention timing. The lack of non-invasive tools for structural and functional assessment can lead to imprecise intervention timing, resulting in unnecessary costs and potentially suboptimal patient outcomes.
Solution
ViTAA Medical offers a non-invasive, AI-powered platform for precision aortic care, providing physicians with detailed strength and weakness maps of abdominal aortic aneurysms (AAA). The platform analyzes existing CT images, incorporating hemodynamic and geometric descriptors with functional measures of wall behavior obtained from ECG-gated multiphase imaging. ViTAA's algorithms compute a vulnerability index, highlighting regions of altered local hemodynamics, thrombus formation, and strain. This enables personalized mapping of the aortic wall, identifying areas of potential rapid growth or rupture risk, ultimately assisting healthcare professionals in diagnosis and treatment planning.
Target Audience
The primary target audience includes vascular surgeons, radiologists, and interventional cardiologists involved in the management and treatment of abdominal aortic aneurysms.
Features
- Analyzes existing CT images to assess aortic aneurysmal tissue.
- Generates Regional Areas of Weakness (RAW™) Maps, providing a functional and structural assessment of the aneurysm.
- Incorporates simulation data on blood flow and intraluminal thrombus (ILT) to compute detailed vulnerability maps.
- Calculates a vulnerability index that captures regions of altered local hemodynamics, thick thrombus formation, and large strain.
- Identifies vulnerable areas of potential aneurysm rapid growth, serving as a clinical surrogate to aneurysm rupture.
- AI-powered analysis for precise timing of aneurysm intervention.